Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

Clinical trial NCT07220694 · RECRUITING

Trial details

NCT number: NCT07220694
Sponsor: SF Research Institute, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Insulin Resistance Mild Cognitive Impairment Cognitive Decline Neurodegenerative Disorders

Start date: 2026-01-29
Primary completion: 2026-03-28
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.